Foley Special Counsel Kyle Faget, member of the firm’s Health Care, Digital Health, and Telemedicine Industry Team, will be presenting during the Food Drug Law Institute’s “Digital Health Technology and Regulation During COVID-19 and Beyond” virtual event on September 10th. Her panel is titled “Regulation of Digital Health During and After COVID-19,” and will take place at 12:05 p.m. ET. She will be joined by Michele Buenafe (Partner, Morgan, Lewis & Bockius LLP), Megan Coder (Executive Director, Digital Therapeutics Alliance), and Kellie Combs (Partner, Ropes & Gray LLP).
The session will discuss and compare the traditional approval pathways available for software-as-medical device products, as well as significant enforcement discretion policies and exemptions, both pre-and post-COVID-19. The panel will examine how FDA’s enforcement trends during COVID-19 have expanded beyond previously delineated requirements for products such as digital health therapeutic devices for psychiatric conditions, and whether those trends are likely to continue beyond the COVID-19 pandemic. The impact of increased funding for telehealth and remote patient monitoring tools under the CARES Act will also be discussed.
To find out more, or register for the webinar, click here.
People
Related Insights
December 22, 2025
Labor & Employment Law Perspectives
‘Tis the Season
‘Tis the Season… You probably do not think of HR compliance when you hear the phrase. But the end of 2025 is a good time — even in the…
January 27, 2026
Events
Fashion Law 2025 Year in Review
In 2025, the fashion industry faced significant challenges and opportunities driven by geopolitical shifts, rising tariffs and trade policy changes, and evolving consumer expectations, while innovation in brand protection and strategic partnerships supported resilience and growth.
December 22, 2025
Foley Viewpoints
Guyana: A Primer on a Strategic U.S. Caribbean & South American Ally
Guyana does not currently have a binding corporate governance code, and minority shareholder protections are relatively weak. Foreign investors must therefore structure joint ventures and other partnerships carefully, using shareholder agreements, board representation rights, and dispute resolution clauses to safeguard their interests.